OBJECTIVES: The aim of the study was the clinical analysis of value of pelvic lymphadenectomy in surgical treatment of @entity1204 . MATERIAL AND METHODS: The group of 420 @entity1 treated for of @entity1204 in stage IA-IV by FIGO 1988 was analysed. All these @entity1 were operated in 2nd Dept. of Obstetrics and Gynecology Medical University of @entity235  sk between 1981-2000. The subgroup of @entity1 with pelvic lymphadenectomy was selected. The data were obtained from case histories. RESULTS: The subgroup of @entity1 on whom pelvic lymphadenectomy was performed was up 32.6% of all treated @entity1 (137 @entity1 ). Neoplastic @entity3 were found in 27 cases (19.7%). All those @entity1 were in clinical stage II-IV by FIGO 1988, and no earlier stage of @entity1204 was found in that group. In every case myometrial invasion was more then 1/2 of myometrium. In 59.2% of neoplastic @entity3 high or medium differential @entity420 were found. CONCLUSION: Pelvic lymphadenectomy has to be part of surgical treatment of @entity1204 . Lymph nodes @entity3 are important prognostic factors. Myometrial invasion plays an important role as a risk factor of lymph nodes @entity3 .

[Clinical value of pelvic lymphadenectomy in surgical treatment of XXXX ].

@entity1204 :: ('MESH:D016889', 'Disease') :: ['endometrial carcinoma', 'endometrial cancer'] @entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity235 :: ('9615', 'Gene') :: ['Gda'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastases'] @entity420 :: ('MESH:D000230', 'Disease') :: ['adenocarcinoma']
@entity1204 :: (MESH:D016889,Disease) :: ['endometrial cancer']
